285 related articles for article (PubMed ID: 15331725)
1. Rheumatoid factors induce signaling from B cells, leading to Epstein-Barr virus and B-cell activation.
Yang L; Hakoda M; Iwabuchi K; Takeda T; Koike T; Kamatani N; Takada K
J Virol; 2004 Sep; 78(18):9918-23. PubMed ID: 15331725
[TBL] [Abstract][Full Text] [Related]
2. B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines, and Burkitt's lymphomas.
Yokochi T; Holly RD; Clark EA
J Immunol; 1982 Feb; 128(2):823-7. PubMed ID: 6274961
[TBL] [Abstract][Full Text] [Related]
3. The B cell repertoire in rheumatoid arthritis. I. Frequency of EBV-inducible circulating precursors producing autoantibodies.
Moynier M; Abderrazik M; Rucheton M; Combe B; Sany J; Brochier J
J Autoimmun; 1991 Aug; 4(4):631-49. PubMed ID: 1663752
[TBL] [Abstract][Full Text] [Related]
4. Binding of monoclonal antibody to the Epstein Barr virus (EBV)/CR2 receptor induces activation and differentiation of human B lymphocytes.
Nemerow GR; McNaughton ME; Cooper NR
J Immunol; 1985 Nov; 135(5):3068-73. PubMed ID: 2995485
[TBL] [Abstract][Full Text] [Related]
5. Suppressive effect of human natural killer cells on Epstein-Barr virus-induced immunoglobulin synthesis.
Kuwano K; Arai S; Munakata T; Tomita Y; Yoshitake Y; Kumagai K
J Immunol; 1986 Sep; 137(5):1462-8. PubMed ID: 3018077
[TBL] [Abstract][Full Text] [Related]
6. Activation of latent EBV via anti-IgG-triggered, second messenger pathways in the Burkitt's lymphoma cell line Akata.
Daibata M; Humphreys RE; Takada K; Sairenji T
J Immunol; 1990 Jun; 144(12):4788-93. PubMed ID: 2161880
[TBL] [Abstract][Full Text] [Related]
7. B cell activation by the nontransforming P3HR-1 substrain of the Epstein-Barr virus (EBV).
Hu CP; Aman P; Masucci MG; Klein E; Klein G
Eur J Immunol; 1986 Jul; 16(7):841-5. PubMed ID: 3013647
[TBL] [Abstract][Full Text] [Related]
8. Effects of recombinant human interferons on rheumatoid arthritis B lymphocytes activated by Epstein-Barr virus.
Lotz M; Tsoukas CD; Curd JG; Carson DA; Vaughan JH
J Rheumatol; 1987 Feb; 14(1):42-5. PubMed ID: 3033238
[TBL] [Abstract][Full Text] [Related]
9. Epstein Barr virus binding induces internalization of the C3d receptor: a novel immunotoxin delivery system.
Tedder TF; Goldmacher VS; Lambert JM; Schlossman SF
J Immunol; 1986 Aug; 137(4):1387-91. PubMed ID: 3016095
[TBL] [Abstract][Full Text] [Related]
10. Activation and infection of B cells by Epstein-Barr virus. Role of calcium mobilization and of protein kinase C translocation.
Dugas B; Delfraissy JF; Calenda A; Peuchmaur M; Wallon C; Rannou MT; Galanaud P
J Immunol; 1988 Dec; 141(12):4344-51. PubMed ID: 2848895
[TBL] [Abstract][Full Text] [Related]
11. Phosphatidylinositol 3-kinase is a determinant of responsiveness to B cell antigen receptor-mediated Epstein-Barr virus activation.
Iwakiri D; Takada K
J Immunol; 2004 Feb; 172(3):1561-6. PubMed ID: 14734735
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneity of EBV-transformable human B lymphocyte populations.
Chan MA; Stein LD; Dosch HM; Sigal NH
J Immunol; 1986 Jan; 136(1):106-12. PubMed ID: 2999241
[TBL] [Abstract][Full Text] [Related]
13. Impaired regulation of Epstein-Barr virus-induced lymphocyte proliferation in rheumatoid arthritis is due to a T cell defect.
Depper JM; Bluestein HG; Zvaifler NJ
J Immunol; 1981 Nov; 127(5):1899-902. PubMed ID: 6271870
[TBL] [Abstract][Full Text] [Related]
14. T cell-mediated immunoregulation of Epstein Barr virus- (EBV) induced B lymphocyte activation in EBV-seropositive and EBV-seronegative individuals.
Tosato G; Magrath IT; Blaese RM
J Immunol; 1982 Feb; 128(2):575-9. PubMed ID: 6274959
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies against gp140, the Epstein-Barr virus and C3d receptor in sera from rheumatoid arthritis patients.
Barel M; Kahan A; Charriaut-Marlangue C; Kahan A; Frade R
Eur J Immunol; 1986 Nov; 16(11):1357-61. PubMed ID: 2946590
[TBL] [Abstract][Full Text] [Related]
16. Relationship between immunoglobulin production and immortalization by Epstein Barr virus.
Tosato G; Blaese RM; Yarchoan R
J Immunol; 1985 Aug; 135(2):959-64. PubMed ID: 2989369
[TBL] [Abstract][Full Text] [Related]
17. Antigen presentation by human B cells: T cell proliferation induced by Epstein Barr virus B lymphoblastoid cells.
Issekutz T; Chu E; Geha RS
J Immunol; 1982 Oct; 129(4):1446-50. PubMed ID: 6286767
[TBL] [Abstract][Full Text] [Related]
18. Immortalization of EBV-infected B cells is not influenced by exogenous signals acting on B cell proliferation. Effects of mutant EL-4 thymoma cells and transforming growth factor-beta.
Straub C; Zubler RH
J Immunol; 1989 Jan; 142(1):87-93. PubMed ID: 2535862
[TBL] [Abstract][Full Text] [Related]
19. The superoxide generating system of B cell lines. Structural homology with the phagocytic oxidase and triggering via surface Ig.
Maly FE; Cross AR; Jones OT; Wolf-Vorbeck G; Walker C; Dahinden CA; De Weck AL
J Immunol; 1988 Apr; 140(7):2334-9. PubMed ID: 2832475
[TBL] [Abstract][Full Text] [Related]
20. Combination of mutant EL-4 thymoma cells and EBV-infection in B lymphocyte activation a) EBV-infection of EL-4-activated lymphocytes. b) Use of EL-4 cells as feeders for lymphoblastoid cell lines.
Barcellini W; Borghi MO; Nicoletti F; Bonara P; Fain C; Meroni PL
J Clin Lab Immunol; 1990 Sep; 33(1):21-8. PubMed ID: 1966941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
